The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer
| dc.contributor.author | Mamlins, Eduards | |
| dc.contributor.author | Scharbert, Lara | |
| dc.contributor.author | Cardinale, Jens | |
| dc.contributor.author | Krotov, Maria | |
| dc.contributor.author | Winter, Erik | |
| dc.contributor.author | Rathke, Hendrik | |
| dc.contributor.author | Strodel, Birgit | |
| dc.contributor.author | Ankrah, Alfred O | |
| dc.contributor.author | Sathekge, Mike Machaba | |
| dc.contributor.author | Haberkorn, Uwe | |
| dc.contributor.author | Kratochwil, Clemens | |
| dc.contributor.author | Giesel, Frederik L. | |
| dc.date.accessioned | 2024-05-10T06:23:15Z | |
| dc.date.available | 2024-05-10T06:23:15Z | |
| dc.date.issued | 2024-02 | |
| dc.description | DATA AVAILABILITY : The data used and/or analyzed during the current study are available from the corresponding author on reasonable request. | en_US |
| dc.description.abstract | Please read abstract in the article. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.librarian | hj2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.sponsorship | Open Access funding enabled and organized by Projekt DEAL. This work was supported by Telix Pharmaceuticals Limited. | en_US |
| dc.description.uri | https://www.springer.com/journal/11307 | en_US |
| dc.identifier.citation | Mamlins, E., Scharbert, L., Cardinale, J. et al. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular Imaging and Biology 26, 81–89 (2024). https://doi.org/10.1007/s11307-023-01881-y. | en_US |
| dc.identifier.issn | 1536-1632 (print) | |
| dc.identifier.issn | 1860-2002 (online) | |
| dc.identifier.other | 10.1007/s11307-023-01881-y | |
| dc.identifier.uri | http://hdl.handle.net/2263/95872 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.rights | © The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. | en_US |
| dc.subject | PSMA-GCK01 | en_US |
| dc.subject | Technetium-99 m | en_US |
| dc.subject | Single-photon emission computed tomography (SPECT) | en_US |
| dc.subject | Theranostics | en_US |
| dc.subject | Prostate cancer | en_US |
| dc.subject | Prostate-specific membrane antigen (PSMA) | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer | en_US |
| dc.type | Article | en_US |